Cargando…
An amplification-free ultra-sensitive electrochemical CRISPR/Cas biosensor for drug-resistant bacteria detection
Continued development of high-performance and cost-effective in vitro diagnostic tools is vital for improving infectious disease treatment and transmission control. For nucleic acid diagnostics, moving beyond enzyme-mediated amplification assays will be critical in reducing the time and complexity o...
Autores principales: | Suea-Ngam, Akkapol, Howes, Philip D., deMello, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494034/ https://www.ncbi.nlm.nih.gov/pubmed/34703560 http://dx.doi.org/10.1039/d1sc02197d |
Ejemplares similares
-
Ultrasensitive and amplification-free detection of SARS-CoV-2 RNA using an electrochemical biosensor powered by CRISPR/Cas13a
por: Kashefi-Kheyrabadi, Leila, et al.
Publicado: (2023) -
Electrochemical biosensor for detecting pathogenic bacteria based on a hybridization chain reaction and CRISPR-Cas12a
por: Liu, Xiu, et al.
Publicado: (2021) -
Amplification-free RNA detection with CRISPR–Cas13
por: Shinoda, Hajime, et al.
Publicado: (2021) -
Electrochemical biosensor for nucleic acid amplification-free and sensitive detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA via CRISPR/Cas13a trans-cleavage reaction
por: Heo, Woong, et al.
Publicado: (2022) -
CRISPR-Cas, Argonaute proteins and the emerging landscape of amplification-free diagnostics
por: Santiago-Frangos, Andrew, et al.
Publicado: (2022)